• 1 March 1975
    • journal article
    • Vol. 2, 261-4
Abstract
The frequency, clinical settings and histopathological correlations of bone marrow involvement in the non-Hodgkin's group of malignant lymphomata is presented. The importance of formal bone marrow biopsy is stressed. The overall frequency of involvement in a prospectively studied group of 109 patients is 41%. In one subgroup, those with nodular lymphocytic poorly differentiated lymphoma, the incidence is 85% in previously untreated patients.